BioCentury
ARTICLE | Company News

Management tracks: WuXi NextCode, Assembly

March 12, 2018 10:37 PM UTC

WuXi NextCode Genomics Inc. (Cambridge, Mass.) said CEO Hannes Smárason is stepping down. He is succeeded by EVP and COO Rob Brainin. Last year, the genomics company raised $240 million in a series B round on its path to a potential IPO (see BioCentury Extra, Sept. 7, 2017).

HBV and microbiome company Assembly Biosciences Inc. (NASDAQ:ASMB) said CFO and COO David Barrett is stepping down. He is succeeded by Graham Cooper. Cooper was CFO of Receptos Inc., which Celgene Corp. (NASDAQ:CELG) acquired...